FIRST AMENDMENT TO COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 9th, 2023 • Caribou Biosciences, Inc. • Biological products, (no disgnostic substances)
This First Amendment to Collaboration and License Agreement (the “Amendment”) is made and entered into effective as of February 21, 2023 (the “Amendment Effective Date”) and is by and between Caribou Biosciences, Inc., a Delaware corporation with its principal place of business at 2929 Seventh St., Suite 105, Berkeley, CA 94710, USA (“Caribou”), and AbbVie Manufacturing Management Unlimited Company, a private unlimited company incorporated under the laws of Ireland with its principal place of business at 2.3 Woodford Business Park, Santry, Dublin 9, Ireland (“AbbVie”). Caribou and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
